Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
Д. В. Буханова(Association of Rheumatologists of Russia), М. Е. Диатроптов, Tatiana V. Dubinina(Lomonosov Moscow State University), Ш. Ф. Эрдес(Russian Academy of Sciences), Б. С. Белов(Unknown), N. N. Yudkina, A. V. Volkov, G. Lukina(Association of Rheumatologists of Russia), N. V. Demidova, Г. М. Тарасова(Association of Rheumatologists of Russia), М. В. Черкасова
Cited by 9
Related Papers
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
|Rheumatology Science and Practice|2021|54
COVID-19: the new challenge for rheumatologists
|Modern Rheumatology Journal|2020|30
Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)
|Meditsinskiy sovet = Medical Council|2019|14
Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review
|Rheumatology Science and Practice|2021|14
Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues
|Rheumatology Science and Practice|2022|13